40 likes | 169 Views
a. b. 2.5. 7. 6. 2.0. 5. 1.5. 4. c ell mortality ratio (%). r elative cell number. 3. 1.0. 2. 0 .5. 1. 0. 0. CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). CN 0.1 0.5 1 5 10 20 30. Sal ( m M ). c. 8. **. 6. Alizarin red S staining
E N D
a b 2.5 7 6 2.0 5 1.5 4 cell mortality ratio (%) relative cell number 3 1.0 2 0.5 1 0 0 CN 0.1 0.5 1 5 10 20 30 Sal (mM) CN 0.1 0.5 1 5 10 20 30 Sal (mM) c 8 ** 6 Alizarin red S staining per total area (%) ** 4 2 ** ** 0 control 0.1 0.5 1 5 10 20 mM Salubrinal Fig. S1
a control Sal 1 2 4 8 24 1 2 4 8 24 h p-eIF2a Sal 8 h (clone 14) eIF2a ATF4 b-actin b Relative mRNA abundance OCN 2.0 ATF4 2.0 ** ** ** 1.5 * ** 1.5 ** 1.0 1.0 0.5 0.5 0 CN Sal5 Sal10 Sal20 0 CN Sal5 Sal10 Sal20 Fig. S2
4 * a b ** 3 cell mortality ratio (%) 2 2.5 1 2.0 0 1.5 CN 5 10 20 relative cell number Gu (mM) 1.0 0.5 6.0 OCN ** 0 c CN 5 10 20 5.0 Gu control Gu (mM) 4.0 Relative mRNA abundance 2 4 8 24 2 4 8 24 h 3.0 p-eIF2a 2.0 * 1.0 eIF2a 0 CN 5 10 20 Gu (mM) ATF4 b-actin d Fig. S3
a 7 b 6 5 cell mortality ratio (%) 4 3 2 1 0 CN Gu Sal RANKL c CN Sal Gu RANKL NFATc1 2.0 b-actin 1.5 relative cell number d 1.0 0.5 0 Relative mRNA abundance Gu Sal CN RANKL NFATc1 TRAP 10 300 200 5 100 0 0 CN Sal RANKL Gu CN Sal RANKL Gu Fig. S4